Cargando…

The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site

GPR139 is an orphan G protein-coupled receptor expressed in the brain, in particular in the habenula, hypothalamus and striatum. It has therefore been suggested that GPR139 is a possible target for metabolic disorders and Parkinson’s disease. Several surrogate agonist series have been published for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nøhr, Anne Cathrine, Jespers, Willem, Shehata, Mohamed A., Floryan, Leonard, Isberg, Vignir, Andersen, Kirsten Bayer, Åqvist, Johan, Gutiérrez-de-Terán, Hugo, Bräuner-Osborne, Hans, Gloriam, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430874/ https://www.ncbi.nlm.nih.gov/pubmed/28442765 http://dx.doi.org/10.1038/s41598-017-01049-z

Ejemplares similares

Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139
por: Shehata, Mohamed A., et al.
Publicado: (2016)

Identification of a novel scaffold for a small molecule GPR139 receptor agonist
por: Nøhr, Anne Cathrine, et al.
Publicado: (2019)

Pharmacology and function of the orphan GPR139 G protein‐coupled receptor
por: Vedel, Line, et al.
Publicado: (2019)

The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW
por: Nøhr, Anne Cathrine, et al.
Publicado: (2017)

Molecular insights into ligand recognition and G protein coupling of the neuromodulatory orphan receptor GPR139
por: Zhou, Yali, et al.
Publicado: (2021)

Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone Toxicity
por: Bayer Andersen, Kirsten, et al.
Publicado: (2016)

Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants
por: Harpsøe, Kasper, et al.
Publicado: (2015)

Identification of Histamine H(3) Receptor Ligands Using a New Crystal Structure Fragment-based Method
por: Frandsen, Ida Osborn, et al.
Publicado: (2017)

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
por: Pataskar, Abhijeet, et al.
Publicado: (2022)

QligFEP: an automated workflow for small molecule free energy calculations in Q
por: Jespers, Willem, et al.
Publicado: (2019)

Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
por: Pataskar, Abhijeet, et al.
Publicado: (2022)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
por: Kaushik, Aman Chandra, et al.
Publicado: (2021)

In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist
por: Shoblock, James R., et al.
Publicado: (2019)

Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT(2) Receptors
por: Isberg, Vignir, et al.
Publicado: (2013)

Correction: Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT(2) Receptors
por: Isberg, Vignir, et al.
Publicado: (2014)

GPCRDB: an information system for G protein-coupled receptors
por: Isberg, Vignir, et al.
Publicado: (2014)

Habenula GPR139 is associated with fear learning in the zebrafish
por: Roy, Nisa, et al.
Publicado: (2021)

Stabilization of tryptophan hydroxylase 2 by l‐phenylalanine‐induced dimerization
por: Tidemand, Kasper D., et al.
Publicado: (2016)

Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
por: Jespers, Willem, et al.
Publicado: (2017)

S39. GPR139 AN OPHAN GPCR AFFECTING NEGATIVE DOMAINS OF SCHIZOPHRENIA
por: Atienza, Joy, et al.
Publicado: (2018)

No Tryptophan, Tyrosine and Phenylalanine Abnormalities in Children with Attention-Deficit/Hyperactivity Disorder
por: Bergwerff, Catharina Elisabeth, et al.
Publicado: (2016)

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

Mutagenesis of GPR139 reveals ways to create gain or loss of function receptors
por: Wang, Lien, et al.
Publicado: (2019)

S180. THE SELECTIVE GPR139 AGONIST TAK-041 REVERSES ANHEDONIA AND SOCIAL INTERACTION DEFICITS IN RODENT MODELS RELATED TO NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Schiffer, Hans, et al.
Publicado: (2020)

Specificity of the Acute Tryptophan and Tyrosine Plus Phenylalanine Depletion and Loading Tests Part II: Normalisation of the Tryptophan and the Tyrosine Plus Phenylalanine to Competing Amino Acid Ratios in a New Control Formulation
por: Badawy, Abdulla A.-B., et al.
Publicado: (2010)

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [(11)C]PHNO PET
por: Rabiner, Eugenii A., et al.
Publicado: (2021)

Re-evaluation of Adrenocorticotropic Hormone and Melanocyte Stimulating Hormone Activation of GPR139 in Vitro
por: Nepomuceno, Diane, et al.
Publicado: (2018)

Deciphering conformational selectivity in the A(2A) adenosine G protein-coupled receptor by free energy simulations
por: Jespers, Willem, et al.
Publicado: (2021)

GPCRdb: an information system for G protein-coupled receptors
por: Isberg, Vignir, et al.
Publicado: (2016)

GPCRdb: an information system for G protein-coupled receptors
por: Isberg, Vignir, et al.
Publicado: (2017)

Novel approaches leading towards peptide GPCR de‐orphanisation
por: Hauser, Alexander S., et al.
Publicado: (2020)

Binary and Ternary Complexes of Cucurbit[8]uril with Tryptophan, Phenylalanine, and Tyrosine: A Computational Study
por: El-Barghouthi, Musa I., et al.
Publicado: (2022)

Heat Capacities of l-Histidine, l-Phenylalanine, l-Proline, l-Tryptophan and l-Tyrosine
por: Pokorný, Václav, et al.
Publicado: (2021)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Multiple tyrosine metabolites are GPR35 agonists
por: Deng, Huayun, et al.
Publicado: (2012)

Familial early puberty: presentation and inheritance pattern in 139 families
por: Durand, Adélaïde, et al.
Publicado: (2016)

Effects of dietary tryptophan and phenylalanine–tyrosine depletion on phasic alertness in healthy adults – A pilot study
por: Hildebrand, Patricia, et al.
Publicado: (2015)

New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
por: Mendive-Tapia, Lorena, et al.
Publicado: (2015)

Determination and Application of Nineteen Monoamines in the Gut Microbiota Targeting Phenylalanine, Tryptophan, and Glutamic Acid Metabolic Pathways
por: Ma, Shu-Rong, et al.
Publicado: (2021)

Cationic Surfactants Based on Arginine-Phenylalanine and Arginine-Tryptophan: Synthesis, Aggregation Behavior, Antimicrobial Activity, and Biodegradation
por: Pérez, Lourdes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgbaf4h86v53h7gg0a5rk0j1j0